NeuroSpace is a pioneering science venture that seeks to revolutionize human experiences using groundbreaking neuroscience-driven sleep technology. Established in 2013, the company operates at the intersection of Health Care, IT, and Platform industries.
With a slogan of "Elevating daily experiences through groundbreaking sleep technology driven by neuroscience," NeuroSpace aims to unlock the mysteries of sleep and elevate human existence to new levels.
The company’s most recent injection of capital, totaling ¥170.00M, came in the form of Debt Financing investment on 08 July 2019, with the participation of Sompo Holdings as the investor.
As NeuroSpace continues to push the boundaries of sleep technology and neuroscience, it stands poised to make significant strides in enhancing human well-being and quality of life.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Debt Financing | ¥170.00M | 1 | 08 Jul 2019 | |
Series A | ¥250.00M | 8 | Tokyu Fudosan, MTG Co., Ltd. +2 | 08 Apr 2019 |
Debt Financing | ¥90.00M | 4 | Tokyo Higashi Shinkin Bank, Sumitomo Mitsui Banking Corporation +1 | 08 Apr 2019 |
Seed Round | ¥100.00M | 4 | Leave a Nest | 18 Oct 2017 |
Seed Round | ¥9.98M | 1 | 01 Dec 2016 |
No recent news or press coverage available for NeuroSpace.